Plasma MIF levels are associated with coronary artery disease (CAD), and we and others have previously detected enhanced MIF expression in atherosclerotic plaques11–14 and demonstrated that MIF promotes atherogenic leukocyte recruitment through non-cognate interaction with the chemokine receptors CXCR2 and CXCR415. The gene discussed is MIF; the disease is coronary artery disorder.